Hinge Health, Inc. (NYSE:HNGE) is one of the stocks Jim Cramer shared his thoughts on. During the episode, Cramer showed a bullish sentiment toward the company stock, as he said:
“… After the quiet period ended mid-June, and Hinge received universally positive coverage from the analysts, the stock then took off again, climbing as high as $52 and change on the last day of June before pulling back to the mid-40s as of today. So I like that nice pullback from the top…
… So the story sounds pretty good, right? Numbers are great, and now the only thing left to determine is how much should we pay for the stock. The 13 analysts that have stuck Buy ratings on Hinge have assigned price targets ranging from $41 to $52… So on an absolute basis, the stock seems a little pricey, trading 87 times this year’s numbers, 60 times next year’s numbers.
However, I don’t think that’s a crazy multiple to pay for a stock in this stage of its development now, when it’s got such rapid growth. With Hinge’s earnings per share expected to grow by 45% next year, the stock has a price to earnings to growth ratio of 1.33 based on these numbers, which is actually far from expensive. In fact, using 2026 numbers, the S&P 500 currently has a 1.5 price to earnings to growth ratio. You could argue that, at least on this metric, Hinge is trading at a discount to the market.
Bottom line: I think Hinge Health looks like another good option for investors like MNTN, Mountain. But unlike the high-flying CoreWeave or the Circle Internet, you know what? You get my blessing right now, right here to buy tomorrow morning. Yeah, I feel that good about it. As we peruse these mid-sized IPOs from the past several weeks, we’re finding some real nice up-and-coming companies with stocks that haven’t run too much, and I think some of them, like Hinge and Mountain, represent really good options for growth-oriented investors like you.”
A professional investor in a bespoke suit calmly analysing a stock exchange chart.
Hinge Health (NYSE:HNGE) develops software focused on joint and muscle care and provides solutions for musculoskeletal conditions, injury recovery, chronic pain, and post-surgical rehabilitation. The company also offers administrative and operational support services.
While we acknowledge the risk and potential of HNGE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HNGE and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Hedge Fund Resource Center